Maynard Ryan D
Insider CIK 1363984 · RIGL EVP & CFO · CARA Chief Financial Officer · LBIO Director · FHTX Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IOVA IOVANCE BIOTHERAPEUTICS, I | A Award deriv | 2026-06-16 | 2026-06-18 | 90,316 | — | $0 | 90,316 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | A Award deriv | 2026-02-23 | 2026-02-24 | 400,000 | $5.75 | $2.30M | 400,000 | SEC↗ |
| IOVA IOVANCE BIOTHERAPEUTICS, I | A Award deriv | 2025-06-13 | 2025-06-17 | 67,546 | — | $0 | 67,546 | SEC↗ |
| IOVA IOVANCE BIOTHERAPEUTICS, I | M Exercise deriv | 2024-11-12 | 2024-11-14 | 50,000 | — | $0 | 0 | SEC↗ |
| IOVA IOVANCE BIOTHERAPEUTICS, I | M Exercise | 2024-11-12 | 2024-11-14 | 50,000 | $7.45 | $372.5K | 57,500 | SEC↗ |
| IOVA IOVANCE BIOTHERAPEUTICS, I | S Sale | 2024-11-12 | 2024-11-14 | 50,000 | $10.06 | $503.0K | 7,500 | SEC↗ |
| IOVA IOVANCE BIOTHERAPEUTICS, I | A Award deriv | 2024-06-11 | 2024-06-13 | 49,303 | — | $0 | 49,303 | SEC↗ |
| IOVA IOVANCE BIOTHERAPEUTICS, I | A Award deriv | 2024-03-01 | 2024-03-05 | 50,000 | — | $0 | 50,000 | SEC↗ |
| CARA Cara Therapeutics, Inc. | A Award | 2024-02-01 | 2024-02-05 | 13,500 | — | $0 | 13,500 | SEC↗ |
| IOVA IOVANCE BIOTHERAPEUTICS, I | A Award deriv | 2023-06-06 | 2023-06-08 | 51,955 | — | $0 | 51,955 | SEC↗ |
| CARA Cara Therapeutics, Inc. | A Award deriv | 2023-03-01 | 2023-03-03 | 81,000 | — | $0 | 81,000 | SEC↗ |
| CARA Cara Therapeutics, Inc. | S Sale | 2023-02-08 | 2024-02-12 | 5,488 | $0.53 | $2.9K | 8,012 | SEC↗ |
| CARA Cara Therapeutics, Inc. | A Award deriv | 2022-09-12 | 2022-09-14 | 225,000 | — | $0 | 225,000 | SEC↗ |
| IOVA IOVANCE BIOTHERAPEUTICS, I | A Award deriv | 2022-06-10 | 2022-06-14 | 51,204 | — | $0 | 51,204 | SEC↗ |
| IOVA IOVANCE BIOTHERAPEUTICS, I | P Buy | 2022-05-31 | 2022-06-02 | 7,500 | $6.75 | $50.6K | 7,500 | SEC↗ |
| IOVA IOVANCE BIOTHERAPEUTICS, I | A Award deriv | 2021-06-29 | 2021-07-01 | 35,000 | — | $0 | 35,000 | SEC↗ |
| IOVA IOVANCE BIOTHERAPEUTICS, I | A Award deriv | 2020-06-08 | 2020-06-10 | 35,000 | — | $0 | 35,000 | SEC↗ |
| IOVA IOVANCE BIOTHERAPEUTICS, I | A Award deriv | 2019-06-10 | 2019-06-11 | 35,000 | — | $0 | 35,000 | SEC↗ |
| IOVA IOVANCE BIOTHERAPEUTICS, I | A Award deriv | 2018-07-17 | 2018-07-19 | 35,000 | — | $0 | 35,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | M Exercise deriv | 2017-11-03 | 2017-11-07 | 100,000 | — | $0 | 75,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | M Exercise | 2017-11-03 | 2017-11-07 | 100,000 | $2.14 | $214.0K | 100,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | S Sale | 2017-11-03 | 2017-11-07 | 100,000 | $3.90 | $390.0K | 0 | SEC↗ |
| LBIO Lion Biotechnologies, Inc. | A Award deriv | 2017-06-01 | 2017-06-05 | 35,000 | — | $0 | 35,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2017-04-19 | 2017-04-21 | 150,000 | — | $0 | 150,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2017-04-19 | 2017-04-21 | 62,500 | — | $0 | 62,500 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2017-02-02 | 2017-02-06 | 150,000 | — | $0 | 150,000 | SEC↗ |
| LBIO Lion Biotechnologies, Inc. | A Award deriv | 2016-08-16 | 2016-08-18 | 35,000 | — | $0 | 35,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2016-04-04 | 2016-04-06 | 175,000 | — | $0 | 175,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2016-04-04 | 2016-04-06 | 62,500 | — | $0 | 62,500 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2016-01-26 | 2016-01-28 | 150,000 | — | $0 | 150,000 | SEC↗ |
| LBIO Lion Biotechnologies, Inc. | A Award deriv | 2015-06-12 | 2015-06-16 | 35,000 | — | $0 | 35,000 | SEC↗ |
| LBIO Lion Biotechnologies, Inc. | A Award deriv | 2015-02-16 | 2015-02-17 | 50,000 | — | $0 | 50,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2015-01-26 | 2015-01-28 | 175,000 | — | $0 | 175,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2014-02-27 | 2014-03-03 | 125,000 | — | $0 | 125,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2013-01-30 | 2013-01-31 | 150,000 | — | $0 | 150,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | M Exercise deriv | 2012-09-12 | 2012-09-14 | 23,302 | — | $0 | 73,300 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | M Exercise deriv | 2012-09-12 | 2012-09-14 | 23,302 | — | $0 | 73,300 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | M Exercise | 2012-09-12 | 2012-09-14 | 23,302 | $6.49 | $151.2K | 23,302 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | S Sale | 2012-09-12 | 2012-09-14 | 23,302 | $10.67 | $248.6K | 0 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | M Exercise deriv | 2012-09-10 | 2012-09-11 | 17,586 | — | $0 | 96,602 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | S Sale | 2012-09-10 | 2012-09-11 | 17,586 | $10.52 | $185.0K | 0 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | M Exercise | 2012-09-10 | 2012-09-11 | 17,586 | $6.49 | $114.1K | 17,586 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | M Exercise deriv | 2012-09-07 | 2012-09-11 | 34,112 | — | $0 | 114,188 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | S Sale | 2012-09-07 | 2012-09-11 | 34,112 | $10.55 | $359.9K | 0 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | M Exercise | 2012-09-07 | 2012-09-11 | 34,112 | $6.49 | $221.4K | 34,112 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | M Exercise | 2012-09-07 | 2012-09-14 | 23,302 | $6.49 | $151.2K | 23,302 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | S Sale | 2012-09-07 | 2012-09-14 | 23,302 | $10.67 | $248.6K | 0 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | M Exercise deriv | 2012-08-07 | 2012-08-09 | 1,700 | — | $0 | 148,300 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | S Sale | 2012-08-07 | 2012-08-09 | 300 | $10.63 | $3.2K | 0 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | M Exercise | 2012-08-07 | 2012-08-09 | 1,700 | $6.49 | $11.0K | 1,700 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | S Sale | 2012-08-07 | 2012-08-09 | 700 | $10.60 | $7.4K | 1,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | S Sale | 2012-08-07 | 2012-08-09 | 600 | $10.62 | $6.4K | 300 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | S Sale | 2012-08-07 | 2012-08-09 | 100 | $10.61 | $1.1K | 900 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2012-01-25 | 2012-01-27 | 150,000 | — | $0 | 150,000 | SEC↗ |